Medullary Thyroid Cancer: Epidemiology and Characteristics According to Data From the Marne-Ardennes Register 1975-2018.

IF 3 Q2 ENDOCRINOLOGY & METABOLISM
Journal of the Endocrine Society Pub Date : 2024-05-13 eCollection Date: 2024-04-06 DOI:10.1210/jendso/bvae084
Sarah Caillé, Adeline Debreuve-Theresette, Géraldine Vitellius, Sophie Deguelte, Luigi La Manna, Mohamad Zalzali
{"title":"Medullary Thyroid Cancer: Epidemiology and Characteristics According to Data From the Marne-Ardennes Register 1975-2018.","authors":"Sarah Caillé, Adeline Debreuve-Theresette, Géraldine Vitellius, Sophie Deguelte, Luigi La Manna, Mohamad Zalzali","doi":"10.1210/jendso/bvae084","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>Medullary thyroid cancer (MTC) is a rare disease.</p><p><strong>Objective: </strong>The main objective of our study was to analyze the incidence evolution of MTC with a follow-up of more than 40 years. Further, a descriptive and survival analysis was performed according to the Kaplan-Meier analysis.</p><p><strong>Design setting and patients: </strong>This is a retrospective epidemiological study using data from the Marne-Ardennes registry from 1975 to 2018. Two hundred sixty patients with MTC were included.</p><p><strong>Main outcome measures: </strong>The incidence was calculated in the territory of the register (Marne and Ardennes departments of France) and standardized on the demographic structure of France. Patient and tumor characteristics were described. An analysis in a subgroup comparing hereditary and sporadic forms was performed. An analysis of survival was performed.</p><p><strong>Results: </strong>The standardized incidence shows an increasing trend over time. The incidence increased significantly from 0.41 to 0.57/100 000 person-years between 1986 and 1996 and 2008 and 2018. The MTC was hereditary in 21.2% of cases. The sex ratio (males:females) was 0.73. The average age at diagnosis was 53 years. Ninety-seven patients (37.3%) were N1, 26 (10%) were M1, and 56 (21.5%) developed metastases during the follow-up. Complete remission was obtained in 58.5% of patients. The disease was refractory for 18.1% of patients. The 5-year survival rate was 88.4%. Sporadic cases had a poorer prognosis than hereditary MTC.</p><p><strong>Conclusion: </strong>Our study demonstrates a moderate increase in the incidence of MTC between 1975 and 2018. The prognosis remains worse for sporadic MTC than for hereditary MTC.</p>","PeriodicalId":17334,"journal":{"name":"Journal of the Endocrine Society","volume":"8 6","pages":"bvae084"},"PeriodicalIF":3.0000,"publicationDate":"2024-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11091837/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Endocrine Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1210/jendso/bvae084","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/4/6 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Context: Medullary thyroid cancer (MTC) is a rare disease.

Objective: The main objective of our study was to analyze the incidence evolution of MTC with a follow-up of more than 40 years. Further, a descriptive and survival analysis was performed according to the Kaplan-Meier analysis.

Design setting and patients: This is a retrospective epidemiological study using data from the Marne-Ardennes registry from 1975 to 2018. Two hundred sixty patients with MTC were included.

Main outcome measures: The incidence was calculated in the territory of the register (Marne and Ardennes departments of France) and standardized on the demographic structure of France. Patient and tumor characteristics were described. An analysis in a subgroup comparing hereditary and sporadic forms was performed. An analysis of survival was performed.

Results: The standardized incidence shows an increasing trend over time. The incidence increased significantly from 0.41 to 0.57/100 000 person-years between 1986 and 1996 and 2008 and 2018. The MTC was hereditary in 21.2% of cases. The sex ratio (males:females) was 0.73. The average age at diagnosis was 53 years. Ninety-seven patients (37.3%) were N1, 26 (10%) were M1, and 56 (21.5%) developed metastases during the follow-up. Complete remission was obtained in 58.5% of patients. The disease was refractory for 18.1% of patients. The 5-year survival rate was 88.4%. Sporadic cases had a poorer prognosis than hereditary MTC.

Conclusion: Our study demonstrates a moderate increase in the incidence of MTC between 1975 and 2018. The prognosis remains worse for sporadic MTC than for hereditary MTC.

甲状腺髓样癌:根据1975-2018年马恩-阿尔登登记数据得出的流行病学和特征。
背景:甲状腺髓样癌是一种罕见疾病:甲状腺髓样癌是一种罕见疾病:我们研究的主要目的是分析随访超过40年的甲状腺髓样癌的发病演变情况。此外,还根据卡普兰-梅尔分析法进行了描述性分析和生存分析:这是一项回顾性流行病学研究,使用的数据来自马恩-阿尔登登记处 1975 年至 2018 年的数据。共纳入了260名MTC患者:发病率按登记地区(法国马恩省和阿登省)计算,并以法国人口结构为标准。对患者和肿瘤特征进行了描述。对遗传性和散发性进行了分组分析。结果:结果:标准化发病率呈逐年上升趋势。1986年至1996年以及2008年至2018年期间,发病率从每10万人年0.41例大幅上升至0.57例。21.2%的 MTC 病例具有遗传性。性别比(男性:女性)为0.73。确诊时的平均年龄为 53 岁。97例患者(37.3%)为N1型,26例(10%)为M1型,56例(21.5%)在随访期间出现转移。58.5%的患者病情完全缓解。18.1%的患者为难治性疾病。5年生存率为88.4%。与遗传性 MTC 相比,散发性病例的预后较差:我们的研究表明,1975年至2018年间,MTC的发病率适度增加。散发性 MTC 的预后仍然比遗传性 MTC 差。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of the Endocrine Society
Journal of the Endocrine Society Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
5.50
自引率
0.00%
发文量
2039
审稿时长
9 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信